Search Videos by Topic or Participant
Browse by Series:

Role of Adjuvant Radiation Therapy in Melanoma

Panelists: Robert H. I. Andtbacka, MD, CM, Huntsman; Omid Hamid, MD, The Angeles Clinic; Merrick I. Ross, MD, MD Anderson; Jeffrey A. Sosman, MD, Vander
Published: Friday, Jul 25, 2014
For High-Definition, Click
Adjuvant radiation therapy reduces the risk of local recurrence in patients with high-risk melanoma, notes Robert H. I. Andtbacka, MD, CM. However, this benefit does not translate into an extension in overall survival or control of distant recurrences. Additionally, Andtbacka notes, radiation therapy is accompanied by increased locoregional symptoms, with areas of the head and neck being less impacted compared with the groin.

If wound healing is sluggish as a result of obesity or other condition, radiation should not be considered, suggests Jeffrey A. Sosman, MD. Additionally, as a result of the added toxicity, treatment selection should focus on the patient’s health and the presences of extracapsular extension. However, even when extracapsular extensions are present, Andtbacka advises against radiation to groin areas.

In the ECOG-1609 trial, adjuvant ipilimumab is being compared with high-dose interferon alfa-2b in patients with high-risk stage III-IV melanoma. In this trial, enrollment does not exclude previous adjuvant radiation therapy, notes Omid Hamid, MD. As a result, findings from this study will provide further information on long-term outcomes with radiation therapy. 
Slider Left
Slider Right
For High-Definition, Click
Adjuvant radiation therapy reduces the risk of local recurrence in patients with high-risk melanoma, notes Robert H. I. Andtbacka, MD, CM. However, this benefit does not translate into an extension in overall survival or control of distant recurrences. Additionally, Andtbacka notes, radiation therapy is accompanied by increased locoregional symptoms, with areas of the head and neck being less impacted compared with the groin.

If wound healing is sluggish as a result of obesity or other condition, radiation should not be considered, suggests Jeffrey A. Sosman, MD. Additionally, as a result of the added toxicity, treatment selection should focus on the patient’s health and the presences of extracapsular extension. However, even when extracapsular extensions are present, Andtbacka advises against radiation to groin areas.

In the ECOG-1609 trial, adjuvant ipilimumab is being compared with high-dose interferon alfa-2b in patients with high-risk stage III-IV melanoma. In this trial, enrollment does not exclude previous adjuvant radiation therapy, notes Omid Hamid, MD. As a result, findings from this study will provide further information on long-term outcomes with radiation therapy. 
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Publication Bottom Border
Border Publication
x